104
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Utilizing Nanotechnology to Recuperate Sorafenib for Lung Cancer Treatment: Challenges and Future Perspective

&
Pages 213-215 | Received 18 Dec 2019, Accepted 20 Dec 2019, Published online: 15 Jan 2020
 

Financial & competing interests’ disclosure

This work was supported by an NIH Research Enhancement Award (R15), 1R15HL138606-01A1 to V Gupta. SK Shukla was supported by research assistantship from NIH-R15 to V Gupta. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.